Monaco Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Monaco Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-25,000	Closed	-$146K	–	93
2024 Q4	$146K	Buy	+25,000	New	+$250K	0.02%	80
2023 Q3	–	Sell	-11,809	Closed	-$107K	–	77
2023 Q2	$107K	Sell	11,809 -210,096	-95%	-$1.27M	0.03%	63
2023 Q1	$770K	Sell	221,905 -129,612	-37%	-$529K	0.24%	52
2022 Q4	$861K	Buy	351,517 +166,246	+90%	+$485K	0.26%	53
2022 Q3	$511K	Buy	185,271 +55,271	+43%	+$234K	0.2%	53
2022 Q2	$529K	Buy	+130,000	New	+$412K	0.23%	54

Other funds holding OLMA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LMC

Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return

Monaco Asset Management's OLMA Position: Q1 2025 in Review

Monaco Asset Management sold out of Olema Pharmaceuticals (OLMA) in Q1 2025, closing a stake of 25,000 shares — an estimated $146K sold.

Monaco Asset Management first reported a position in OLMA in Q2 2022 and held it in 6 quarters. The position peaked at $861K in Q4 2022. 133 funds tracked by Wall St. Rank hold OLMA as of Q1 2025.

Monaco Asset Management reported no remaining Olema Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
Monaco Asset Management sold 25,000 Olema Pharmaceuticals shares in Q1 2025, an estimated $146K.
Monaco Asset Management first reported a position in Olema Pharmaceuticals in Q2 2022 and held it in 6 quarters.
Monaco Asset Management's Olema Pharmaceuticals position peaked at $861K in Q4 2022.
133 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2025.

Based on Monaco Asset Management's 13F filing for Q1 2025, filed 8 May 2025.